Code | CSB-MP005511HU |
Abbreviation | Recombinant Human CLDN9 protein-VLPs (Active) |
MSDS | |
Size | $570 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
This Human Claudin-9 (CLDN9) recombinant protein was produced in Mammalian cell, where the gene sequence encoding Human CLDN9 (1-217aa) was expressed with the C-terminal 10xHis tag. The activity was validated.
In addition, this Human CLDN9 recombinant protein was developed through the Virus-Like Particles (VLPs) Platform. It is a four-pass transmembrane protein.
Applications : Drug related studies
Review: CLDN9 is considered a potential target for the treatment of cancer and other diseases. It is a four-times transmembrane protein that is very difficult to express the full-length protein. The recombinant human CLDN9 protein expressed by CUSABIO through its VLP platform has complete biological activity. I used the CSB-MP005511HU product and the anti-CLDN9 antibody (CSB-RA005508MA1HU) for an ELISA experiment, and the EC50 was measured to be 0.8032-2.566 ng/ml. Our company has purchased many VLP proteins from CUSABIO, and they have all demonstrated excellent activity, making significant contributions to our drug development and research. CUSABIO is a powerful company since its VLP products are very distinctive.
By Anonymous